Table 5.

Associations of selected predictors with SCORE2 levels, analysed using linear regression and stratified by patient and control subgroup.

		Psoriasis Patients		Control
	Age Category	B (95% CI)	p Value	B (95% CI)	p Value
Gender	<50 years	−1.22 (−2.29|0.14)	0.27	−0.32 (−0.94|0.31)	0.315
	50–69 years	1.85 (−4.71|0.01)	0.198	1.93 (−2.91|6.77)	0.416
Age	<50 years	0.13 (0.06|0.19)	<0.001	0.02 (−0.03|0.06)	0.448
	50–69 years	0.56 (0.37|0.74)	<0.001	0.29 (−0.12|0.71)	0.157
BMI	<50 years	0.09 (−0.03|0.21)	0.142	0.04 (−0.04|0.12)	0.295
	50–69 years	0.06 (−0.27|0.39)	0.708	0.11 (−0.32|0.55)	0.596
WC	<50 years	0.05 (0.00|0.09)	0.036	0.01 (−0.03|0.04)	0.698
	50–69 years	0.06 (−0.07|0.19)	0.376	−0.10 (−0.32|0.13)	0.372
Psoriasis	<50 years	0.05 (−0.02|0.12)	0.164
duration	50–69 years	0.12 (0.03|0.21)	0.012
PASI	<50 years	0.10 (0.01|0.19)	0.037
	50–69 years	0.23 (0.01|0.45)	0.044